Wang Yong Yang

Title: Innovations of Wang Yong Yang in Antibacterial Agents

Introduction

Wang Yong Yang is a notable inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optically active compounds with antibacterial properties. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.

Latest Patents

Wang Yong Yang's latest patents focus on optically active quinoline carboxylic acid derivatives. These derivatives contain 7-pyrrolidine substituents that induce optical activity. The first patent describes a process for preparing these compounds, which include their pharmaceutically acceptable salts and solvates. The compounds exhibit superior antibacterial activity and pharmacokinetic profiles compared to their enantiomers and conventional antibacterial agents, with minimal phototoxicity. The second patent similarly details optically active quinoline carboxylic acid derivatives with 4-aminomethyl-4-methyl-3-(Z)-alkoxyiminopyrrolidine substituents, also demonstrating significant antibacterial efficacy.

Career Highlights

Wang Yong Yang is currently associated with Dongwha Pharm. Ind. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research focuses on developing new antibacterial agents that can effectively combat resistant strains of bacteria.

Collaborations

Wang has collaborated with notable colleagues such as Sung June Yoon and Yong Ho Chung, contributing to the advancement of research in his field.

Conclusion

Wang Yong Yang's contributions to the development of optically active quinoline carboxylic acid derivatives highlight his role as a key innovator in the pharmaceutical industry. His work promises to enhance the effectiveness of antibacterial treatments, addressing critical health challenges.